Connection

Sara Giordano to Triple Negative Breast Neoplasms

Back to Details
This is a "connection" page, showing publications Sara Giordano has written about Triple Negative Breast Neoplasms.
Sara Giordano
Connection Strength
0.128
Triple Negative Breast Neoplasms
  1. Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579). Breast Cancer Res Treat. 2015 Jun; 151(3):629-38.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.